Pretreatment GFR Slopes Predict Dapagliflozin Response in IgA Nephropathy
Dapagliflozin was associated with a slower eGFR decline in patients with IgAN, particularly those with a steeper pretreatment eGFR slope, suggesting that pretreatment eGFR slope may help guide individualized therapy.
Authors
- Takaya Sasaki (ORCID: https://orcid.org/0000-0001-9525-2638)
- Shinya Yokote (ORCID: https://orcid.org/0000-0002-0252-4313)
- Masahiro Okabe (ORCID: https://orcid.org/0000-0002-0059-3542)
- Shohei Fukunaga (ORCID: https://orcid.org/0000-0002-5905-2476)
- Nobuo Tsuboi (ORCID: https://orcid.org/0000-0002-5407-5265)
- Kei Matsumoto
- Hiroyuki Ueda (ORCID: https://orcid.org/0000-0002-3938-2208)
- Takashi Yokoo
- Akihiro Shimizu (ORCID: https://orcid.org/0009-0003-4783-175X)
Institutions
- Jikei University School of Medicine (JP)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.ekir.2025.04.042
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59